Vasopressin Transdermal Patch 0.4 mg/24hr

Controlled-release transdermal patch delivering 0.4 mg vasopressin over 24 hours for chronic diabetes insipidus management. Note specifies transdermal systems; classified 3004.39.0045 as measured-dose hormone product of heading 2937.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
๐Ÿ‡จ๐Ÿ‡ณChinaFreeโ€”Free
๐Ÿ‡ฒ๐Ÿ‡ฝMexicoFreeโ€”Free
๐Ÿ‡จ๐Ÿ‡ฆCanadaFreeโ€”Free
๐Ÿ‡ฉ๐Ÿ‡ชGermanyFreeโ€”Free
๐Ÿ‡ฏ๐Ÿ‡ตJapanFreeโ€”Free

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Higher: 10% vs Free

If other transdermal systems without specified hormones

Vasopressin specificity uses 0045 suffix; general transdermals fall to 9091 statistical breakout.

8713.10.00.00Higher: 10% vs Free

If imported as wearable medical appliance without drug reservoir

Drug-free patches may classify as Chapter 90 appliances; active medicament controls Chapter 30.

3304.99.50.00Higher: 35% vs Free

If marketed for cosmetic skin delivery without therapeutic claims

Chapter note excludes beauty preparations; medical hormone use prevents cosmetic shift.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

โ€ข Adhesive matrix composition and permeation testing reports required for device-drug combo clearance

โ€ข Shelf-life extension data critical for transdermal stability during ocean freight

Related Products under HTS 3004.39.00.45

Vasostrict Vasopressin IV Solution 100 Units/5mL

Brand-name Vasostrict intravenous vasopressin solution in 5 mL ampules (20 units/mL concentration) for septic shock and GI hemorrhage treatment. HTS 3004.39.0045 applies to this measured-dose hormone injection containing synthetic vasopressin of heading 2937.

Terlipressin Acetate Injection 1 mg Vial

Synthetic vasopressin analog terlipressin acetate lyophilized powder for injection (1 mg/vial) reconstituted for variceal bleeding control. HTS 3004.39.0045 covers this measured-dose product containing heading 2937 vasopressin-related hormone.

Desmopressin Sublingual Film 120 mcg Strip

Dissolvable oral thin film strips containing 120 mcg desmopressin for rapid absorption in nocturnal enuresis treatment, packaged in individual foil pouches. HTS 3004.39.0045 for this measured-dose vasopressin analog (2937 hormone) in prophylactic form.

Lypressin Intranasal Solution 50 mcg/mL

Lypressin (lysine vasopressin) aqueous nasal solution at 50 mcg/mL concentration in metered pump bottles for diabetes insipidus. Falls under 3004.39.0045 as therapeutic hormone (2937) in measured prophylactic doses.

Vasopressin Injection 20 Units/mL Vial

A sterile injectable solution of vasopressin (synthetic antidiuretic hormone) in a 1 mL single-dose vial, used for treating diabetes insipidus and controlling bleeding during endoscopy. Classified under HTS 3004.39.0045 as a mixed product containing vasopressin (heading 2937 hormone) put up in measured doses for therapeutic use. Excludes goods of headings 3002, 3005, or 3006.

Desmopressin Acetate Nasal Spray 10 mcg/spray

Nasal spray formulation of desmopressin acetate (vasopressin analog) delivering 10 mcg per spray for nocturnal enuresis and diabetes insipidus management. Falls under HTS 3004.39.0045 as it contains a heading 2937 hormone product in measured-dose metered spray for therapeutic prophylactic use.